Profile data is unavailable for this security.
About the company
Scandion Oncology A/S is a manufacturer of biological products. The Company was founded in May 2017 and is located in Copenhagen, Denmark. It focuses on modern onclogy, the treatment of cancers that have developed resistance to chemotherapy.
- Revenue in SEK (TTM)--
- Net income in SEK--
- Incorporated2017
- Employees--
- LocationScandion Oncology A/SSymbion, Fruebjergvej 3KOEBENHAVN 2100DenmarkDNK
- Websitehttps://scandiononcology.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dextech Medical AB | 0.00 | -5.14m | 89.29m | 1.00 | -- | 2.35 | -- | -- | -0.2966 | -0.2966 | 0.00 | 2.06 | 0.00 | -- | -- | -- | -23.11 | -36.80 | -23.29 | -38.28 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 13.26 | -- | -18.38 | -- |
| ISR Immune System Rgultn Hldg AB (publ) | 0.00 | -257.16m | 96.61m | -- | -- | -- | -- | -- | -3.65 | -3.65 | 0.00 | -2.39 | 0.00 | -- | -- | -- | -1,169.75 | -111.37 | -- | -155.17 | -- | -- | -- | -- | -- | -128,581.00 | -- | -- | -- | -- | -152.98 | -- | -- | -- |
| PCI Biotech Holding ASA | 4.96m | -76.64m | 99.72m | 17.00 | -- | 1.51 | -- | 20.11 | -1.97 | -1.97 | 0.1273 | 1.70 | 0.0416 | -- | 0.5862 | 279,529.40 | -64.25 | -33.17 | -72.79 | -36.55 | -- | -- | -1,545.58 | -762.80 | -- | -- | 0.0221 | -- | -14.86 | -9.75 | -22.36 | -- | -- | -- |
| Lidds AB | 4.37m | -36.67m | 102.55m | 3.00 | -- | 2.19 | -- | 23.48 | -0.9805 | -0.9805 | 0.1166 | 0.6733 | 0.0874 | -- | 8.89 | -- | -73.34 | -18.73 | -88.78 | -19.85 | -- | -- | -839.40 | -878.39 | -- | -18,330.50 | 0.00 | -- | 930.15 | -- | -15.27 | -- | -29.79 | -- |
| Bioextrax AB publ | 545.90k | -15.78m | 106.89m | -- | -- | 4.32 | -- | 195.80 | -1.01 | -1.01 | 0.0347 | 0.971 | 0.0332 | -- | 3.26 | -- | -95.97 | -- | -123.03 | -- | -86.52 | -- | -2,890.40 | -- | -- | -22,539.96 | 0.00 | -- | 1,166.12 | -- | -89.02 | -- | -- | -- |
| Lipum AB (publ) | 0.00 | -54.24m | 108.69m | -- | -- | 24.12 | -- | -- | -11.98 | -11.98 | 0.00 | 0.5886 | 0.00 | -- | -- | -- | -144.61 | -- | -166.87 | -- | -- | -- | -- | -- | -- | -- | 0.3449 | -- | -100.00 | -- | -147.69 | -- | -- | -- |
| Nordic Nanovector ASA | 0.00 | -453.04m | 116.67m | 40.00 | -- | 0.6124 | -- | -- | -4.20 | -4.20 | 0.00 | 1.57 | 0.00 | -- | -- | 0.00 | -107.68 | -69.82 | -153.00 | -88.28 | -- | -- | -- | -636,940.80 | -- | -- | 0.00 | -- | -- | -- | -5.81 | -- | -29.60 | -- |
| Scandion Oncology A/S | -100.00bn | -100.00bn | 123.59m | -- | -- | 0.9448 | -- | -- | -- | -- | -- | 3.21 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0072 | -- | -- | -- | -217.81 | -- | -- | -- |
| Isofol Medical AB (publ) | 15.65m | -195.59m | 126.63m | 15.00 | -- | 0.6889 | -- | 8.09 | -4.22 | -4.22 | 0.124 | 1.14 | 0.0441 | -- | 1.17 | 1,043,000.00 | -55.10 | -61.04 | -69.25 | -74.66 | -1,086.11 | -- | -1,250.18 | -1,186.01 | -- | -- | 0.0023 | -- | -39.63 | -- | -5.96 | -- | -- | -- |
| Coegin Pharma AB | 0.00 | -35.59m | 131.22m | -- | -- | 5.37 | -- | -- | -0.0516 | -0.0516 | 0.00 | 0.0264 | 0.00 | -- | -- | -- | -142.04 | -- | -158.13 | -- | -- | -- | -- | -- | -- | -1,546.57 | 0.00 | -- | -- | -- | 41.29 | -- | -- | -- |
| Alzinova AB | 0.00 | -10.81m | 133.24m | -- | -- | 1.21 | -- | -- | -0.4388 | -0.4388 | 0.00 | 3.40 | 0.00 | -- | -- | -- | -10.34 | -8.30 | -10.66 | -8.62 | -- | -- | -- | -- | -- | -476.84 | 0.00 | -- | -- | -- | -16.19 | -- | 28.46 | -- |
| Toleranzia AB | 0.00 | -8.14m | 134.03m | -- | -- | 1.10 | -- | -- | -0.0673 | -0.0673 | 0.00 | 1.10 | 0.00 | -- | -- | -- | -6.19 | -12.63 | -6.43 | -13.30 | -- | -- | -- | -- | -- | -- | 0.0069 | -- | -- | -- | -27.68 | -- | 55.48 | -- |
| 2cureX AB | 8.00k | -28.86m | 137.30m | -- | -- | 2.71 | -- | 17,162.84 | -1.76 | -1.76 | 0.0005 | 2.88 | 0.0001 | -- | 0.0011 | -- | -42.42 | -23.18 | -44.73 | -27.65 | -176,600.00 | -88,517.02 | -360,787.50 | -94,872.34 | -- | -- | 0.00 | -- | -- | -- | -158.70 | -- | -37.81 | -- |
| Peptonic Medical AB | 36.14m | -73.58m | 144.43m | -- | -- | 0.8296 | -- | 4.00 | -0.2277 | -0.2277 | 0.1075 | 0.1435 | 0.4188 | 1.04 | 3.39 | -- | -85.26 | -38.78 | -113.84 | -45.55 | 60.91 | -- | -203.61 | -223.58 | 0.5254 | -38.84 | 0.2223 | -- | -10.10 | -- | -115.39 | -- | -16.66 | -- |
| Aqua Bio Technology ASA | 1.68m | -23.68m | 153.18m | 2.00 | -- | 19.31 | -- | 91.08 | -1.13 | -1.13 | 0.0804 | 0.3677 | 0.0644 | 0.6606 | 1.50 | -- | -90.75 | -73.71 | -152.91 | -100.31 | -117.42 | -41.86 | -1,408.30 | -2,046.06 | 0.3127 | -12.49 | 0.4955 | -- | 250.98 | -- | -33.32 | -- | 56.78 | -- |
| Xintela AB | 0.00 | -78.22m | 154.71m | -- | -- | -- | -- | -- | -0.5315 | -0.5315 | 0.00 | -0.0085 | 0.00 | -- | -- | -- | -302.11 | -119.65 | -559.20 | -180.99 | -- | -- | -- | -12,122.00 | 0.3763 | -17.76 | -- | -- | -- | -- | -19.76 | -- | 27.36 | -- |
Data as of Feb 02 2023. Currency figures normalised to Scandion Oncology A/S's reporting currency: Swedish Krona SEK
0.25%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Tellus Fonder ABas of 31 Aug 2020 | 101.31k | 0.25% |
Data from 31 Aug 2020 - 31 Aug 2020Source: FactSet Research Systems Inc.
